Skip to main content
SpringerLink
Log in

Discovery of novel DPP IV inhibitors: application of pharmacophore-based virtual screening

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Dipeptidyl peptidase IV (DPP-IV) is a potential drug target for type-2 diabetes and DPP-IV inhibitors are known to efficiently improve glucose tolerance. In the present study, pharmacophore model for a set of 29 DPP-IV inhibitors was generated by ligand-based pharmacophore generation process. The best hypothesis, hypo 1, consisting of four chemical features, namely, one hydrogen bond donor, one hydrogen bond acceptor, one hydrophobe and one ring aromatic was validated by cost function analysis, test set prediction and Fischer test. The validated pharmacophore model was then used for searching new lead compounds from Maybridge and NCI database. Four compounds (CD01797, CD06202, CD02493, and AW01077) from Maybridge database and three compounds (NSC997, NSC2450, and NSC5815) from NCI database were identified as structurally diverse druggable novel leads with nM activity against DPP-IV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  • Ahren B, Holst JJ, Martensson H, Balkan B (2000) Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV. Eur J Pharmacol 404:239–245

    Article  PubMed  CAS  Google Scholar 

  • Balkan B, Kwasnik L, Miserendino R, Holst JJ, Li X (1999) Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats. Diabetologia 42:1324–1331

    Article  PubMed  CAS  Google Scholar 

  • Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4:187–217

    Article  CAS  Google Scholar 

  • Deacon CF, Hughes TE, Holst JJ (1998) Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon like peptide 1 in the anesthetized pig. Diabetes 47:764–769

    Article  PubMed  CAS  Google Scholar 

  • Holst JJ (1994) Glucagon-like peptide-1 (GLP-1) a newly discovered GI hormone. Gastroenterology 107:1048–1055

    Google Scholar 

  • Holst JJ, Deacon CF (1998) Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. Diabetes 47:1663–1670

    Article  PubMed  CAS  Google Scholar 

  • Jacotot E, Callebaut C, Blanco J, Krust B, Neubert K, Barth A, Hovanessian AG (1996) Dipeptidyl-peptidase IV-B, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Eur J Biochem 239:248–258

    Article  PubMed  CAS  Google Scholar 

  • Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Wantanabe T, Drucker DJ, Wagtmann N (2000) Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci USA 97:6864–6879

    Article  Google Scholar 

  • Mentlein R (1999) Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85:9–24

    Article  PubMed  CAS  Google Scholar 

  • Mentlein R, Gallwitz B, Schmidt WE (1993) Dipeptidylpeptidase IV hydrolyzes gastric inhibitory polypeptide, glucagon like peptide-1 (7-36), peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214:829–835

    Article  PubMed  CAS  Google Scholar 

  • Paliwal S, Pal M, Yadav D, Singh S, Yadav R (2011) Ligand-based drug design studies using predictive pharmacophore model generation on 4H-1,2,4-triazoles as AT1 receptor antagonists. Med Chem Res. doi:10.1007/s00044-011-9756-4

  • Pederson RP, White HA, Schlenzig D, Pauly RP, McIntosh CRP, Demuth HU (1998) Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47:1253–1258

    Article  PubMed  CAS  Google Scholar 

  • Rachman J, Borrow BA, Levy JC, Turner RC (1997) Near normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide 1 (GLP-1) in subjects with NIDDM. Diabetologia 40:205–211

    Article  PubMed  CAS  Google Scholar 

  • Wettergren A, Schjoldager B, Martensen PE, Myhre J, Christiansen J, Holst JJ (1993) Truncated GLP-1 (proglucagon 72-107 amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38:665–673

    Article  PubMed  CAS  Google Scholar 

  • Yaron A, Nadier F (1993) Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28:31–81

    Article  PubMed  CAS  Google Scholar 

  • Zhonghua P, Xiaofeng L, Kenton L, Thomas WG, Paul EW, Thomas HL, Bradley AZ, Kent S, Stephen JB, Michael AS, Amanda KM, David WAB, Michelle L, Heidi W, Anita JKG, David JM, Todd SM, Lakshmi B, Michael GF, Daisy P, Larry RS, Marc RL, Rohinton E, Elizabeth HF, Hing LS, James MT (2006) Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors. J Med Chem 49:3520–3535

    Article  Google Scholar 

Download references

Acknowledgment

Computational resources were provided by Banasthali University, and the authors thank the Vice Chancellor, for extending the necessary facilities.

Conflict of interest

The authors have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Banasthali University, Banasthali, 304022, Rajasthan, India

    Jyoti Sharma, Divya Yadav & Sarvesh Paliwal

Authors
  1. Jyoti Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Divya Yadav
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarvesh Paliwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarvesh Paliwal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, J., Yadav, D. & Paliwal, S. Discovery of novel DPP IV inhibitors: application of pharmacophore-based virtual screening. Med Chem Res 22, 558–572 (2013). https://doi.org/10.1007/s00044-012-0044-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-012-0044-8

Keywords

Search

Navigation